The role of the microbiota in the management of intensive care patients

P Szychowiak, K Villageois-Tran, J Patrier… - Annals of intensive …, 2022 - Springer
The composition of the gut microbiota is highly dynamic and changes according to various
conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence …

Gut microbiota, antibiotic therapy and antimicrobial resistance: a narrative review

B Pilmis, A Le Monnier, JR Zahar - Microorganisms, 2020 - mdpi.com
Antimicrobial resistance is a major concern. Epidemiological studies have demonstrated
direct relationships between antibiotic consumption and emergence/dissemination of …

MEGARes 2.0: a database for classification of antimicrobial drug, biocide and metal resistance determinants in metagenomic sequence data

E Doster, SM Lakin, CJ Dean, C Wolfe… - Nucleic acids …, 2020 - academic.oup.com
Antimicrobial resistance (AMR) is a threat to global public health and the identification of
genetic determinants of AMR is a critical component to epidemiological investigations. High …

Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: an update

E Ruppé, A Andremont, L Armand-Lefèvre - Travel medicine and infectious …, 2018 - Elsevier
Background Enterobacteriaceae have become increasingly resistant, especially due to the
acquisition and spread of extended-spectrum beta-lactamases (ESBLs), which confer …

Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: what impact on …

PL Woerther, R Lepeule, C Burdet… - International journal of …, 2018 - Elsevier
The ongoing pandemic of extended-spectrum β-lactamase-producing Enterobacteriaceae
(ESBL-E) is responsible for a global rise in carbapenem consumption that may hasten the …

Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art

A Andremont, J Cervesi, PA Bandinelli, F Vitry… - Drug Discovery …, 2021 - Elsevier
Highlights•The gut microbiota is regarded nowadays as a key component for human
health.•Dysbiosis is an unrecognized disease whose consequences just begin to be …

Comparative review of imipenem/cilastatin versus meropenem

A Salmon-Rousseau, C Martins, M Blot… - Médecine et Maladies …, 2020 - Elsevier
Introduction Carbapenems are broad-spectrum antibacterial molecules. Imipenem-cilastatin
and meropenem are the two main molecules used in French healthcare services. Objective …

Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage

E Ruppé, C Burdet, N Grall… - Clinical …, 2018 - clinicalmicrobiologyandinfection …
Antibiotic resistance is increasing worldwide and poses a fundamental, long-term threat to
human health. Solutions tackling antibiotic resistance include the protection of our intestinal …

Metagenomic characterization of gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following …

S Leo, V Lazarevic, M Girard, N Gaïa, J Schrenzel… - Microorganisms, 2020 - mdpi.com
Background: The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying
Intervention Strategies) WP3 study was the first multicenter randomized clinical trial …

Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates

SYL Holbrook, S Garneau-Tsodikova - Microbial drug resistance, 2018 - liebertpub.com
Pseudomonas aeruginosa, a Gram-negative bacterium, is a member of the ESKAPE
pathogens and one of the leading causes of healthcare-associated infections worldwide …